Log In
person
Xeris Biopharma Holdings Inc
XERS
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Hypoglycemia Treatment Products |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
153.36M | 93.56% |
| Hypoglycemia Treatment Products |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
10.55M | 6.44% |
| keyboard_arrow_down |
Hypoglycemia Treatment Products
Branded Pharmaceuticals (outsourced)
|
153.36M | 93.56% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Hypoglycemia Treatment Products
Pre-Revenue Pharmaceuticals
|
10.55M | 6.44% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||